Get Live Data

The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. Dunedin Ent.it. Share Price
  4. Dunedin Ent.it. Share Regulatory News
  5. Portfolio Update

Pin to quick picksDunedin Ent.it. Regulatory News (DNE)

Dunedin Ent.it. Information

Share Price Information for Dunedin Ent.it. (DNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 490.00
Bid: 474.00
Ask: 510.00
Change: 9.00 (1.87%)
Spread: 36.00 (7.595%)
Open: 490.00
High: 490.00
Low: 490.00
Prev. Close: 481.00
DNE Live PriceLast checked at -
Dunedin Enterprise is an Investment Trust

To conduct an orderly realisation of its assets, to be effected in a manner that seeks to achieve a balance between maximising the value of the investments and progressively returning cash to Shareholders.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Portfolio Update

25 Aug 2022 09:15

RNS Number : 2150X
Dunedin Enterprise Inv Trust PLC
25 August 2022
 

Dunedin Enterprise Investment Trust PLC

 

Date: 25 August 2022

LEI: 213800E2VLUZ5AF9Z434

 

RED realisation

 

Dunedin Enterprise Investment Trust PLC is pleased to announce that Dunedin Buyout Fund II LP has entered into a legally binding agreement to realise the investment in RED, the provider of SAP contract and permanent staff. The transaction is subject to funding and regulatory approvals and is expected to complete in the second half of 2022.

 

The investment in RED was valued at £23.7m in the Preliminary Unaudited Net Asset Value at 30/06/22 published on 1 August 2022. Proceeds from the sale are expected to amount to £23.7m, consisting of capital of £19.7m and income of £4.0m. Additionally, there are future potential proceeds from an earn-out arrangement which are dependent upon RED achieving profit targets in the year to 31 March 2023.

 

Following funding and regulatory approvals being received the Board intends to announce a distribution to shareholders.

 

 

END

 

 

For further information please contact:

Dunedin LLP

Graeme Murray 07813138367

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PFUFIFLTTFIEFIF
123456789
Date   Source Headline
11th May 20222:58 pmRNSResult of AGM
11th May 20221:26 pmRNS1st Quarter Results
3rd May 20227:00 amRNSPreliminary unaudited net asset value at 31/3/22
13th Apr 202210:47 amRNSDirector/PDMR Shareholding
21st Mar 202212:43 pmRNSPortfolio Update
18th Mar 20227:00 amRNSAnnual Financial Report
2nd Mar 202212:41 pmRNSHolding(s) in Company
11th Feb 20227:00 amRNSDividend Declaration
1st Feb 20227:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/21
16th Dec 20213:28 pmRNSDirector/PDMR Shareholding
15th Dec 20217:00 amRNSPortfolio Update
8th Dec 202110:05 amRNSListing Rule 9.6.14
1st Dec 202110:02 amRNSDirector/PDMR Shareholding
1st Dec 202110:01 amRNSDirector/PDMR Shareholding
26th Nov 202112:45 pmRNSDirector/PDMR Shareholding
26th Nov 202112:44 pmRNSDirector/PDMR Shareholding
26th Nov 202112:42 pmRNSDirector/PDMR Shareholding
24th Nov 20217:56 amRNSDirector/PDMR Shareholding
24th Nov 20217:54 amRNSDirector/PDMR Shareholding
24th Nov 20217:46 amRNSHolding(s) in Company
19th Nov 20218:18 amRNSHolding(s) in Company
19th Nov 20217:00 amRNS3rd Quarter Results
16th Nov 20217:00 amRNSResult of Tender Offer
10th Nov 202111:43 amRNSResult of General Meeting
1st Nov 20217:00 amRNSQ3 Preliminary NAV and Tender Offer Price
18th Oct 20219:20 amRNSTender Offer
13th Oct 202110:00 amRNSPortfolio Update
6th Oct 20217:00 amRNSDividend Declaration
21st Sep 202110:00 amRNSCapital Reorganisation
16th Sep 20217:00 amRNSHalf-year Report
2nd Aug 20217:00 amRNSPreliminary Unaudited Net Asset Value at 30/6/21
30th Jul 202112:25 pmRNSCapital Reorganisation
7th Jul 20211:13 pmRNSPortfolio Update
21st Jun 202110:28 amRNSDirector/PDMR Shareholding
12th May 20212:42 pmRNSResult of AGM
12th May 202111:31 amRNS1st Quarter Results
4th May 20217:00 amRNSPreliminary unaudited net asset value at 31/3/21
16th Mar 20218:41 amRNSDirector/PDMR Shareholding
16th Mar 20218:41 amRNSDirector/PDMR Shareholding
16th Mar 20218:20 amRNSDirector/PDMR Shareholding
16th Mar 20218:19 amRNSDirector/PDMR Shareholding
16th Mar 20218:18 amRNSDirector/PDMR Shareholding
15th Mar 20217:00 amRNSAnnual Financial Report
26th Feb 20217:00 amRNSPortfolio Update
1st Feb 20217:00 amRNSPreliminary Unaudited Net Asset Value at 31/12/20
20th Nov 20207:47 amRNSDirector/PDMR Shareholding
20th Nov 20207:46 amRNSDirector/PDMR Shareholding
20th Nov 20207:44 amRNSDirector/PDMR Shareholding
20th Nov 20207:43 amRNSDirector/PDMR Shareholding
20th Nov 20207:42 amRNSDirector/PDMR Shareholding
123456789

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.